Common Contracts
49 similar At-the-Market Issuance Sales Agreement contracts by Microvision, Inc., Mannkind Corp, Microvision Inc, others
MicroVision, Inc. Common Stock (par value $0.001 per share) At-The-Market Issuance Sales AgreementAt-the-Market Issuance Sales Agreement • August 29th, 2023 • Microvision, Inc. • Electronic components, nec • New York
MicroVision, Inc., a Delaware corporation (the “Company”), confirms its agreement (this “Agreement”) with Craig-Hallum Capital Group LLC (“Craig-Hallum”), as follows:
MicroVision, Inc. Common Stock (par value $0.001 per share) At-The-Market Issuance Sales AgreementAt-the-Market Issuance Sales Agreement • June 21st, 2021 • Microvision, Inc. • Electronic components, nec • New York
MicroVision, Inc., a Delaware corporation (the “Company”), confirms its agreement (this “Agreement”) with Craig-Hallum Capital Group LLC (“Craig-Hallum”), as follows:
MicroVision, Inc. Common Stock (par value $0.001 per share) At-The-Market Issuance Sales AgreementAt-the-Market Issuance Sales Agreement • February 16th, 2021 • Microvision, Inc. • Electronic components, nec • New York
MicroVision, Inc., a Delaware corporation (the “Company”), confirms its agreement (this “Agreement”) with Craig-Hallum Capital Group LLC (“Craig-Hallum”), as follows:
MicroVision, Inc. Common Stock (par value $0.001 per share) At-The-Market Issuance Sales AgreementAt-the-Market Issuance Sales Agreement • December 29th, 2020 • Microvision, Inc. • Electronic components, nec • New York
MicroVision, Inc., a Delaware corporation (the “Company”), confirms its agreement (this “Agreement”) with Craig-Hallum Capital Group LLC (“Craig-Hallum”), as follows:
MicroVision, Inc. Common Stock (par value $0.001 per share) At-The-Market Issuance Sales AgreementAt-the-Market Issuance Sales Agreement • November 9th, 2020 • Microvision, Inc. • Electronic components, nec • New York
MicroVision, Inc., a Delaware corporation (the “Company”), confirms its agreement (this “Agreement”) with Craig-Hallum Capital Group LLC (“Craig-Hallum”), as follows:
EX-10.1 2 d30339_ex10-1.htm EX-10.1 EXECUTION VERSION BIODEL INC. Common Stock (par value $0.01 per share) At-the-Market Issuance Sales Agreement May 13, 2013At-the-Market Issuance Sales Agreement • May 5th, 2020 • New York
VICAL INCORPORATED Common Stock (par value $0.01 per share) At-The-Market Issuance Sales AgreementAt-the-Market Issuance Sales Agreement • October 17th, 2016 • Vical Inc • Biological products, (no disgnostic substances) • New York
Vical Incorporated, a Delaware corporation (the “Company”), confirms its agreement (this “Agreement”) with IFS Securities, Inc. (doing business as Brinson Patrick, a division of IFS Securities, Inc. (“BP”), as follows:
At-the-Market Issuance Sales AgreementAt-the-Market Issuance Sales Agreement • August 26th, 2015 • Anadigics Inc • Semiconductors & related devices • New York
Common Stock (par value $0.001 per share) At-the-Market Issuance Sales AgreementAt-the-Market Issuance Sales Agreement • June 11th, 2015 • LIGHTBRIDGE Corp • Services-management consulting services • New York
Lightbridge Corporation, a Nevada corporation (the “Company”), confirms its agreement (this “Agreement”), with MLV & Co. LLC (“MLV”), as follows:
MEDICINOVA, INC. Common Stock (par value $0.001 per share) At-the-Market Issuance Sales AgreementAt-the-Market Issuance Sales Agreement • May 22nd, 2015 • Medicinova Inc • Pharmaceutical preparations • New York
MediciNova, Inc., a Delaware corporation (the “Company”), confirms its agreement (this “Agreement”), with MLV & Co. LLC (“MLV”), as follows:
GASTAR EXPLORATION INC. Common Stock (par value $0.001 per share)At-the-Market Issuance Sales Agreement • May 7th, 2015 • Gastar Exploration Inc. • Crude petroleum & natural gas • New York
Gastar Exploration Inc., a Delaware corporation (the “Company”), confirms its agreement (this “Agreement”) with MLV & Co. LLC (“MLV”), as follows:
MicroVision, Inc. Common Stock (par value $0.001 per share) At-The-Market Issuance Sales AgreementAt-the-Market Issuance Sales Agreement • May 5th, 2015 • Microvision Inc • Electronic components, nec • New York
MicroVision, Inc., a Delaware corporation (the “Company”), confirms its agreement (this “Agreement”) with Meyers Associates, L.P. (doing business as BP Capital, a division of Meyers Associates, L.P. (“BP”), as follows:
At-the-Market Issuance Sales AgreementAt-the-Market Issuance Sales Agreement • April 9th, 2015 • CorMedix Inc. • Pharmaceutical preparations • New York
At-The-Market Issuance Sales AgreementAt-the-Market Issuance Sales Agreement • April 2nd, 2015 • Emerald Oil, Inc. • Crude petroleum & natural gas • New York
Emerald Oil, Inc., a Delaware corporation (the “Company”), confirms its agreement (this “Agreement”) with MLV & Co. LLC, a Delaware limited liability company (“MLV”), as follows:
At-The-Market Issuance Sales AgreementAt-the-Market Issuance Sales Agreement • February 10th, 2015 • PostRock Energy Corp • Crude petroleum & natural gas • New York
PostRock Energy Corporation, a Delaware corporation (the “Company”), confirms its agreement (this “Agreement”) with MLV & Co. LLC, a Delaware limited liability company (“MLV”), as follows:
CVSL INC. Common Stock (par value $0.0001 per share) At-the-Market Issuance Sales AgreementAt-the-Market Issuance Sales Agreement • December 3rd, 2014 • CVSL Inc. • Retail-nonstore retailers • New York
SYNTA PHARMACEUTICALS CORP. Common Stock (par value $0.0001 per share) At the Market Issuance Sales AgreementAt the Market Issuance Sales Agreement • July 18th, 2014 • Synta Pharmaceuticals Corp • Pharmaceutical preparations • New York
Synta Pharmaceuticals Corp., a Delaware corporation (the “Company”), confirms its agreement (this “Agreement”) with MLV & Co. LLC, a Delaware limited liability company (“MLV”), as follows:
MicroVision, Inc. Common Stock (par value $0.001 per share) At-The-Market Issuance Sales AgreementAt-the-Market Issuance Sales Agreement • June 17th, 2014 • Microvision Inc • Electronic components, nec • New York
MicroVision, Inc., a Delaware corporation (the “Company”), confirms its agreement (this “Agreement”) with Meyers Associates, L.P. (doing business as Brinson Patrick, a division of Meyers Associates, L.P. (“BP”), as follows:
RAIT FINANCIAL TRUST UP TO $150,000,000 Up to 4,000,000 7.75% Series A Cumulative Redeemable Preferred Shares Up to 1,000,000 8.375% Series B Cumulative Redeemable Preferred Shares Up to 1,000,000 8.875% Series C Cumulative Redeemable Preferred Shares...At the Market Issuance Sales Agreement • June 13th, 2014 • RAIT Financial Trust • Real estate investment trusts • New York
RAIT Financial Trust, a Maryland real estate investment trust (the “Company”), confirms its agreement (this “Agreement”) with MLV & Co. LLC (“MLV”), as follows:
At-the-Market Issuance Sales AgreementAt-the-Market Issuance Sales Agreement • May 9th, 2014 • BSD Medical Corp • Electromedical & electrotherapeutic apparatus • New York
BSD Medical Corporation, a Delaware corporation (the “Company”), confirms its agreement (this “Agreement”), with MLV & Co. LLC (“MLV”), as follows:
SYNTA PHARMACEUTICALS CORP. Common Stock (par value $0.0001 per share) At the Market Issuance Sales AgreementAt the Market Issuance Sales Agreement • May 8th, 2014 • Synta Pharmaceuticals Corp • Pharmaceutical preparations • New York
Synta Pharmaceuticals Corp., a Delaware corporation (the “Company”), confirms its agreement (this “Agreement”) with MLV & Co. LLC, a Delaware limited liability company (“MLV”), as follows:
VICAL INCORPORATED Common Stock (par value $0.01 per share) At-The-Market Issuance Sales AgreementAt-the-Market Issuance Sales Agreement • April 15th, 2014 • Vical Inc • Biological products, (no disgnostic substances) • New York
Vical Incorporated, a Delaware corporation (the “Company”), confirms its agreement (this “Agreement”) with Meyers Associates, L.P. (doing business as Brinson Patrick, a division of Meyers Associates, L.P. (“BP”), as follows:
OCULUS INNOVATIVE SCIENCES, INC. Common Stock (par value $0.0001 per share) At- the-Market Issuance Sales AgreementAt-the-Market Issuance Sales Agreement • April 2nd, 2014 • Oculus Innovative Sciences, Inc. • Surgical & medical instruments & apparatus • New York
Oculus Innovative Sciences, Inc., a Delaware corporation (the “Company”), confirms its agreement (this “Agreement”), with MLV & Co. LLC (“MLV”), as follows:
ZAZA ENERGY CORPORATION Common Stock (par value $0.01 per share) At-the-Market Issuance Sales AgreementAt-the-Market Issuance Sales Agreement • March 31st, 2014 • ZaZa Energy Corp • Crude petroleum & natural gas • New York
ZaZa Energy Corporation, a Delaware corporation (the “Company”), confirms its agreement (this “Agreement”), with MLV & Co. LLC (“MLV”), as follows:
At-the-Market Issuance Sales AgreementAt-the-Market Issuance Sales Agreement • March 24th, 2014 • Actinium Pharmaceuticals, Inc. • Blank checks • New York
Actinium Pharmaceuticals, Inc., a Delaware corporation (the “Company”), confirms its agreement (this “Agreement”), with MLV & Co. LLC (“MLV”), as follows:
MANNKIND CORPORATION Common Stock (par value $0.01 per share) At-The-Market Issuance Sales AgreementAt-the-Market Issuance Sales Agreement • March 3rd, 2014 • Mannkind Corp • Pharmaceutical preparations • New York
MannKind Corporation, a Delaware corporation (the “Company”), confirms its agreement (this “Agreement”) with Meyers Associates, L.P. (doing business as Brinson Patrick, a division of Meyers Associates, L.P. (“BP”), as follows:
MANNKIND CORPORATION Common Stock (par value $0.01 per share) At-The-Market Issuance Sales AgreementAt-the-Market Issuance Sales Agreement • March 3rd, 2014 • Mannkind Corp • Pharmaceutical preparations • New York
MannKind Corporation, a Delaware corporation (the “Company”), confirms its agreement (this “Agreement”) with MLV & Co. LLC (“MLV”), as follows:
TARGACEPT, INC. Common Stock (par value $0.001 per share) At-the-Market Issuance Sales AgreementAt-the-Market Issuance Sales Agreement • November 26th, 2013 • Targacept Inc • Pharmaceutical preparations • New York
INSPIREMD, INC. Common Stock (par value $0.0001 per share) At-the-Market Issuance Sales AgreementAt-the-Market Issuance Sales Agreement • October 24th, 2013 • InspireMD, Inc. • Surgical & medical instruments & apparatus • New York
At the Market Issuance Sales AgreementAt the Market Issuance Sales Agreement • October 16th, 2013 • Ligand Pharmaceuticals Inc • Pharmaceutical preparations • New York
Ligand Pharmaceuticals Incorporated, a Delaware corporation (the “Company”), confirms its agreement (this “Agreement”) with MLV & Co. LLC (“MLV”), as follows:
KALOBIOS PHARMACEUTICALS, INC. Common Stock (par value $0.001 per share) At- the-Market Issuance Sales AgreementAt-the-Market Issuance Sales Agreement • September 3rd, 2013 • Kalobios Pharmaceuticals Inc • Pharmaceutical preparations • New York
KaloBios Pharmaceuticals, Inc., a Delaware corporation (the “Company”), confirms its agreement (this “Agreement”), with MLV & Co. LLC (“MLV”), as follows:
TG THERAPEUTICS, INC. Common Stock (par value $0.001 per share) At-the-Market Issuance Sales AgreementAt-the-Market Issuance Sales Agreement • June 21st, 2013 • Tg Therapeutics, Inc. • Pharmaceutical preparations • New York
ONCOGENEX PHARMACEUTICALS, INC. Common Stock (par value $0.001 per share) At- the-Market Issuance Sales AgreementAt-the-Market Issuance Sales Agreement • June 18th, 2013 • Oncogenex Pharmaceuticals, Inc. • In vitro & in vivo diagnostic substances • New York
OncoGenex Pharmaceuticals, Inc., a Delaware corporation (the “Company”), confirms its agreement (this “Agreement”), with MLV & Co. LLC (“MLV”), as follows:
At-the-Market Issuance Sales AgreementAt-the-Market Issuance Sales Agreement • May 20th, 2013 • Pizza Inn Holdings, Inc /Mo/ • Wholesale-groceries & related products • New York
Pizza Inn Holdings, Inc., a Missouri corporation (the “Company”), confirms its agreement (this “Agreement”), with MLV & Co. LLC (“MLV”), as follows:
At-the-Market Issuance Sales AgreementAt-the-Market Issuance Sales Agreement • May 13th, 2013 • Biodel Inc • Pharmaceutical preparations • New York
